APOD and COVID-19: We also found abnormalities in apolipoprotein levels in COVID-19 survivors 6 months after discharge; specifically, apolipoprotein D (APOD) and apolipoprotein M (APOM) levels were demonstrated to be reduced (Fig. 2B).